Viscosupplementation Market Research Report –Forecast till 2027

Viscosupplementation Market: By Hyaluronic Acid Type (Stabilized Hyaluronic Acid), By Procedure Type (Three-Injection Procedure), By Application-Forecast till 2027

ID: MRFR/HC/5788-CR | March 2019 | Region: Global | 137 Pages         

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 18

3.2 Scope of the Study 18

3.3 Assumptions & Limitations 18

3.3.1 Assumptions 18

3.3.2 Limitations 18

3.4 Market Structure 19

4 Research Methodology

4.1 Research Process 21

4.2 Primary Research 22

4.3 Secondary Research 23

4.4 Market Size Estimation 24

4.5 Forecast Model 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 27

5.2.1 Increasing patient pool suffering from knee osteoarthritis 27

5.2.2 Rising popularity of minimally invasive procedures 27

5.2.3 Increasing geriatric population 27

5.3 Restraints 28

5.3.1 Stringent government regulations 28

5.3.2 Rise in insurance denials for viscosupplementation 28

5.4 Opportunity 28

5.4.1 Growing demand from emerging nations 28

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 30

6.1.1 Bargaining Power of Suppliers 30

6.1.2 Bargaining Power of Buyers 31

6.1.3 Threat of New Entrants 31

6.1.4 Threat of Substitutes 31

6.1.5 Rivalry 31

6.2 Supply Chain Analysis 32

6.2.1 R&D and Development 32

6.2.2 Manufacturing 32

6.2.3 Distribution & Sales 32

6.2.4 Post-Sales Monitoring 33

7 Viscosupplementation Market, by Hyaluronic Acid Type

7.1 Introduction 35

7.2 Stabilized Hyaluronic Acid 37

7.3 Standard Hyaluronic Acid 38

8 Viscosupplementation Market, by Procedure Type

8.1 Introduction 40

8.2 Three-injection Procedure 42

8.3 Single-injection Procedure 43

8.4 Five-injection Procedure 44

9 Viscosupplementation Market, by Application

9.1 Introduction 46

9.2 Knee Arthritis 48

9.3 Hip Osteoarthritis 49

10 Viscosupplementation Market, by End-User

10.1 Introduction 51

10.2 Hospitals & Clinics 52

10.3 Ambulatory Surgical Centers 53

11 Global Viscosupplementation Market, by Region

11.1 Introduction 55

11.2 Americas 56

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.2.1 North America 59

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.2.1.1 US 61

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.2.1.2 Canada 62

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.2.2 Latin America 64

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3 Asia-Pacific 67

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.1 Japan 70

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.2 China 72

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.3 India 74

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.4 Australia 76

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.5 South Korea 78

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.3.6 Rest of Asia-Pacific 80

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4 Europe 83

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1 Western Europe 86

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.1 UK 88

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.2 France 90

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.3 Germany 92

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.4 Spain 94

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.5 Italy 96

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.1.6 Rest of Western Europe 98

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.4.2 Eastern Europe 100

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.5 Middle East & Africa 103

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.5.1 Middle East 106

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

11.5.2 Africa 108

Viscosupplementation Market, by Hyaluronic Acid Type

Viscosupplementation Market, by Procedure Type

Viscosupplementation Market, by Application

Viscosupplementation Market, by End-User

12 Competitive Landscape

12.1 Introduction 111

12.2 Company Ranking 111

13 Company Profiles

13.1 Sanofi 113

13.1.1 Company Overview 113

13.1.2 Financial Overview 113

13.1.3 Products/Services Offered 114

13.1.4 Key Developments 114

13.1.5 SWOT Analysis 114

13.1.6 Key Strategies 114

13.2 Allergan 115

13.2.1 Company Overview 115

13.2.2 Financial Overview 115

13.2.3 Products/Services Offered 116

13.2.4 Key Developments 116

13.2.5 SWOT Analysis 116

13.2.6 Key Strategies 116

13.3 F. Hoffmann-La Roche Ltd 117

13.3.1 Company Overview 117

13.3.2 Financial Overview 117

13.3.3 Products/Services Offered 117

13.3.4 Key Developments 117

13.3.5 SWOT Analysis 118

13.3.6 Key Strategies 118

13.4 Zimmer Biomet 119

13.4.1 Company Overview 119

13.4.2 Financial Overview 119

13.4.3 Products/Services Offered 119

13.4.4 Key Developments 120

13.4.5 SWOT Analysis 120

13.4.6 Key Strategies 120

13.5 Smith & Nephew 121

13.5.1 Company Overview 121

13.5.2 Financial Overview 121

13.5.3 Products/Services Offered 121

13.5.4 Key Developments 122

13.5.5 SWOT Analysis 122

13.5.6 Key Strategies 122

13.6 Anika Therapeutics Inc. 123

13.6.1 Company Overview 123

13.6.2 Financial Overview 123

13.6.3 Products/Services Offered 124

13.6.4 Key Developments 124

13.6.5 SWOT Analysis 124

13.6.6 Key Strategies 124

13.7 Fidia Farmaceutici s.p.a. 125

13.7.1 Company Overview 125

13.7.2 Financial Overview 125

13.7.3 Products/Services Offered 125

13.7.4 Key Developments 125

13.7.5 SWOT Analysis 126

13.7.6 Key Strategies 126

13.8 Ferring B.V. 127

13.8.1 Company Overview 127

13.8.2 Financial Overview 127

13.8.3 Products/Services Offered 127

13.8.4 Key Developments 127

13.8.5 SWOT Analysis 128

13.8.6 Key Strategies 128

13.9 Bioventus 129

13.9.1 Company Overview 129

13.9.2 Financial Overview 129

13.9.3 Products/Services Offered 129

13.9.4 Key Developments 129

13.9.5 SWOT Analysis 130

13.9.6 Key Strategies 130

13.10 Regen Lab SA 131

13.10.1 Company Overview 131

13.10.2 Financial Overview 131

13.10.3 Products/Services Offered 131

13.10.4 Key Developments 131

13.10.5 SWOT Analysis 132

13.10.6 Key Strategies 132

14 Appendix

14.1 Discussion Blue Print 134

15 List of Tables

TABLE 1 MARKET SYNOPSIS 16

TABLE 2 PRIMARY INTERVIEWS 21

TABLE 3 GLOBAL VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL VISCOSUPPLEMENTATION MARKET FOR STABILIZED HYALURONIC ACID, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL VISCOSUPPLEMENTATION MARKET FOR STANDARD HYALURONIC ACID, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 41

TABLE 7 GLOBAL VISCOSUPPLEMENTATION MARKET FOR THREE-INJECTION PROCEDURE, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 8 GLOBAL VISCOSUPPLEMENTATION MARKET FOR SINGLE-INJECTION PROCEDURE, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 9 GLOBAL VISCOSUPPLEMENTATION MARKET FOR FIVE-INJECTION PROCEDURE, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 10 GLOBAL VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 47

TABLE 11 GLOBAL VISCOSUPPLEMENTATION MARKET FOR KNEE ARTHRITIS, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 12 GLOBAL VISCOSUPPLEMENTATION MARKET FOR HIP OSTEOARTHRITIS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 13 GLOBAL VISCOSUPPLEMENTATION MARKET, BY END-USERS, 2020–2027 (USD MILLION) 52

TABLE 14 GLOBAL VISCOSUPPLEMENTATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 52

TABLE 15 GLOBAL VISCOSUPPLEMENTATION MARKET FOR AMBULATORY SURGICAL CENTRES, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 16 GLOBAL VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 17 AMERICAS: VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 18 AMERICAS: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 57

TABLE 19 AMERICAS: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 57

TABLE 20 AMERICAS: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 21 AMERICAS: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 58

TABLE 22 NORTH AMERICA: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 23 NORTH AMERICA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 59

TABLE 24 NORTH AMERICA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 59

TABLE 25 NORTH AMERICA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 26 NORTH AMERICA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 27 US: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 61

TABLE 28 US: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 61

TABLE 29 US: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 30 US: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 31 CANADA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 62

TABLE 32 CANADA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 63

TABLE 33 CANADA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 34 CANADA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 35 LATIN AMERICA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 64

TABLE 36 LATIN AMERICA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 65

TABLE 37 LATIN AMERICA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 38 LATIN AMERICA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 39 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68

TABLE 40 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 68

TABLE 41 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 69

TABLE 42 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69

TABLE 43 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 44 JAPAN: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 70

TABLE 45 JAPAN: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 71

TABLE 46 JAPAN: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 71

TABLE 47 JAPAN: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 72

TABLE 48 CHINA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 72

TABLE 49 CHINA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 73

TABLE 50 CHINA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 51 CHINA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 52 INDIA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 74

TABLE 53 INDIA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 75

TABLE 54 INDIA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 55 INDIA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 56 AUSTRALIA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 76

TABLE 57 AUSTRALIA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 77

TABLE 58 AUSTRALIA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77

TABLE 59 AUSTRALIA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 78

TABLE 60 SOUTH KOREA: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 78

TABLE 61 SOUTH KOREA: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 79

TABLE 62 SOUTH KOREA: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 63 SOUTH KOREA: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 80

TABLE 64 REST OF ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 80

TABLE 65 REST OF ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 81

TABLE 66 REST OF ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 67 REST OF ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET, BY END USER, 2020–2027 (USD MILLION) 82

TABLE 68 EUROPE: VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 83

TABLE 69 EUROPE: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 84

TABLE 70 EUROPE: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 84

TABLE 71 EUROPE: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 85

TABLE 72 EUROPE: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 85

TABLE 73 WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86

TABLE 74 WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 86

TABLE 75 WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 87

TABLE 76 WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 77 WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 88

TABLE 78 UK: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 88

TABLE 79 UK: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 89

TABLE 80 UK: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 81 UK: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 90

TABLE 82 FRANCE: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 90

TABLE 83 FRANCE: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 91

TABLE 84 FRANCE: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 85 FRANCE: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 92

TABLE 86 GERMANY: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 92

TABLE 87 GERMANY: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 93

TABLE 88 GERMANY: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 89 GERMANY: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 94

TABLE 90 SPAIN: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 94

TABLE 91 SPAIN: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 95

TABLE 92 SPAIN: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 93 SPAIN: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 96

TABLE 94 ITALY: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 96

TABLE 95 ITALY: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 97

TABLE 96 ITALY: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 97

TABLE 97 ITALY: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 98

TABLE 98 REST OF WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 98

TABLE 99 REST OF WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 99

TABLE 100 REST OF WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 99

TABLE 101 REST OF WESTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 100

TABLE 102 EASTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 100

TABLE 103 EASTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 101

TABLE 104 EASTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 101

TABLE 105 EASTERN EUROPE: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 102

TABLE 106 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 103

TABLE 107 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 104

TABLE 108 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 104

TABLE 109 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 110 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 105

TABLE 111 MIDDLE EAST: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 106

TABLE 112 MIDDLE EAST: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 106

TABLE 113 MIDDLE EAST: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 107

TABLE 114 MIDDLE EAST: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 107

TABLE 115 AFRICA: VISCOSUPPLEMENTATION MARKET BY HYALURONIC ACID TYPE, 2020–2027 (USD MILLION) 108

TABLE 116 AFRICA: VISCOSUPPLEMENTATION MARKET BY PROCEDURE TYPE, 2020–2027 (USD MILLION) 108

TABLE 117 AFRICA: VISCOSUPPLEMENTATION MARKET BY APPLICATION, 2020–2027 (USD MILLION) 109

TABLE 118 AFRICA: VISCOSUPPLEMENTATION MARKET BY END-USER, 2020–2027 (USD MILLION) 109

 

16 List of Figures

FIGURE 1 GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET STRUCTURE 19

FIGURE 2 RESEARCH PROCESS 21

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 24

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VISCOSUPPLEMENTATION MARKET 26

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL VISCOSUPPLEMENTATION MARKET 30

FIGURE 6 SUPPLY CHAIN: GLOBAL VISCOSUPPLEMENTATION MARKET 32

FIGURE 7 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY TYPE, 2020(%) 35

FIGURE 8 GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 35

FIGURE 9 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY PROCEDURE TYPE, 2020 (%) 40

FIGURE 10 GLOBAL VISCOSUPPLEMENTATION MARKET, BY PROCEDURE TYPE, 2020 & 2027 (USD MILLION) 40

FIGURE 11 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY APPLICATION, 2020(%) 46

FIGURE 12 GLOBAL VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 46

FIGURE 13 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY END-USER, 2020(%) 51

FIGURE 14 GLOBAL VISCOSUPPLEMENTATION MARKET, BY END-USER, 2020 & 2027 (USD MILLION) 51

FIGURE 15 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY REGION, 2020(%) 55

FIGURE 16 GLOBAL VISCOSUPPLEMENTATION MARKET, BY REGION, 2020 & 2027 (USD MILLION) 55

FIGURE 17 AMERICAS: VISCOSUPPLEMENTATION MARKET SHARE, BY REGION, 2020 (%) 56

FIGURE 18 ASIA-PACIFIC: VISCOSUPPLEMENTATION MARKET SHARE, BY COUNTRY, 2020 (%) 67

FIGURE 19 EUROPE: VISCOSUPPLEMENTATION MARKET SHARE, BY REGION, 2020 (%) 83

FIGURE 20 MIDDLE EAST & AFRICA: VISCOSUPPLEMENTATION MARKET SHARE, BY REGION, 2020 (%) 103

Viscosupplementation market

global viscosupplementation market is expected to grow USD 3.80 billion at a CAGR of 9.37% from 2022 to 2030.

Segmentation

By Hyaluronic Acid Type Stabilized Hyaluronic Acid
By Procedure Type Three Injection Procedure

Key Players

  • Allergan
  • Sanofi
  • Hoffmann-La Roche
  • Smith & Nephew Plc
  • Zimmer Biomet
  • Anika Therapeutics Inc.
  • Ferring B.V.
  • Bioventus
  • Fidia Farmaceutici S.P.A.

Drivers

  • Rising Popularity Of Minimally Invasive Procedures
  • Increasing Geriatric Population
Speak to Analyst Request a Free Sample

Viscosupplementation Market Overview


Viscosupplements available in the market have shown clinical efficacy and are the most effective treatment for knee osteoarthritis. Osteoarthritis is a chronic painful degenerative joint disease and is the leading cause of chronic disability. The viscosupplementation market is expected to acquire a significant market value of USD 5,243.19 Million while expanding at a CAGR of 10.48% during the forecast period. The rising prevalence of knee osteoarthritis, the growing demand for minimally invasive procedures, and the escalating geriatric population are some salient factors that can augment the viscosupplementation market size during the forecast period. On the other hand, stringent government regulations and the mounting denials of insurance for viscosupplementation products are likely to hamper the global viscosupplementation market growth during the assessment timeframe.


Even in middle-income and low-income countries, the global health community and governments have increasingly prioritized the treatment of numerous chronic diseases. As a result, the desire for proper treatment and cure to meet the global osteoarthritis load has increased dramatically, resulting in a surge in the use and adoption of viscosupplementation. Because the older population is prone to several musculoskeletal illnesses, including osteoarthritis, the global geriatric population would increase the growth of the investigated segment over the projection period.


Impact of COVID-19

The outbreak of COVID-19 is expected to create a significant impact on the growth of the viscosupplementation global market. The imposition of lockdown for the prevention of COVID-19 is has brought a negative impact on the global viscosupplementation market. However, the key players of the viscosupplementation market are adopting various strategies that can make a significant contribution in uplifting the market in the coming period.

Market Dynamics

The growing preference for single injection treatment of osteoarthritis is expected to positively impact the market growth in the assessment period. The increasing adoption of a sedentary lifestyle, smoking, and changing lifestyle are some of the other salient causes that are resulting in osteoarthritis and osteoporosis among the expanding population. 

Drivers

Increasing Incidence of Knee Osteoarthritis to Promote the Viscosupplementation Global Market

Knee osteoarthritis is one of the most common ailments prevalent among the geriatric population. The rising cases of cardiovascular diseases, depression, obesity, renal failure, hypertension, and gastrointestinal bleeding are expected to grow the demand for viscosupplement therapy, thereby augmenting the market during the assessment period.

Opportunities

Integration of Proprietary Technology to Offer Significant Opportunities

The established players of the market are focusing on developing cross-linked hyaluronic acid to provide instant relief from pain. The on-going advancement is expected to offer a significant opportunity to augment the viscosupplementation market share.

Restraints

Lack of Efficiency to Hamper the Market

The lack of efficiency and the high prices associated with hyaluronic acid treatment are expected to hamper the market growth during the assessment period.

Challenges

Safety of Products to Pose a Significant Challenge to the Market

The safety concerns associated to the product are likely to pose a significant challenge to the market expansion during the assessment period.

Market Segmentation

The Viscosupplementation Global Market is segmented into Procedure Type, Hyaluronic Acid Type, Application, and End-User.

By Procedure Type

The procedure type based segments of the global viscosupplementation market are single-injection procedure, three-injection procedure, and five-injection procedure. Among all, the three-injection procedure segment is expected to dominate the market due to the lower cost of these products and the shorter treatment regimen in comparison to five-injection procedure products. The single-injection procedure is predicted to acquire the second-largest market, followed by the five-injection procedure for the viscosupplements market. The three-injection procedure is the leading segment, which is likely to grow at the highest CAGR to reach USD 2602.58 million by the end of 2023.

By Hyaluronic Acids

The hyaluronic acid type based segments of the global viscosupplementation market are standard hyaluronic acid and stabilized hyaluronic acid. Between the two segments, the stabilized hyaluronic acid segment is expected to acquire the largest market share owing to the higher quality of the product.

By Application

The application-type based segments of the global viscosupplementation market are knee arthritis and hip osteoarthritis.  Between the two segments, the knee arthritis segment is expected to account for a larger market share than hip osteoarthritis.

By End-User

The end-user type based segments of the global viscosupplementation market are hospitals & clinics, and ambulatory surgical centers. Between the two, the hospitals & clinics segment is anticipated to procure a larger market share due to the increasing visit of osteoporosis patients in the hospitals & clinics.

Regional Analysis

North America to Expand at the Highest CAGR during the Review Period

As per the viscosupplementation global market report prepared by MRFR, North America is expected to dominate the global market while expanding at the highest CAGR during the assessment period. The growth of the region can be attributed to the growing demand for minimally invasive viscosupplementation procedures for the treatment of knee osteoarthritis. Furthermore, the presence of advanced healthcare infrastructure established key players, and increasing demand for viscosupplementation products are likely to propel the regional market.

APAC to Value USD 447.24 million by 2023

The Asia-Pacific region is expected to acquire the second-largest market share. APAC is estimated to procure a market value of USD 447.24 million while expanding at a CAGR of 10.48% by 2023. The low-cost manufacturing in India and China is likely to expedite the production facilities that can augment the regional market in the projection timeframe. Furthermore, the increasing initiatives taken by the developing countries to develop their healthcare infrastructure is likely to augment the regional trade during the projection timeframe.

Europe to Expand Owing to Rising Geriatric Population

Europe is anticipated to grow during the forecast period owing to the rising geriatric population. The market in the region is likely to show a significant rise owing to the growing product innovation in the coming period. Among all European countries, the UK is anticipated to make a notable contribution in augmenting the regional market.

MEA to Show Steady Growth during the Assessment Period

MEA is anticipated to show significant growth during the forecast period owing to the growing awareness and the increasing initiatives taken by the countries to develop their healthcare infrastructure.

Competitive Analysis

The market is highly fragmented, and the renowned players are adopting various expansion strategies such as; new product launches, joint ventures, acquisitions, and partnerships. These initiatives are likely to enhance market competition.

Key Players Profiled in the Report



  • Allergan

  • Sanofi

  • Hoffmann-La Roche

  • Smith & Nephew Plc

  • Zimmer Biomet

  • Anika Therapeutics Inc.

  • Ferring B.V.

  • Bioventus

  • Fidia Farmaceutici S.P.A.

  • Regen Lab SA


Recent News


Sep 2021 Viscosupplementation with hyaluronic acid, also known as "gel injections," is available at Vitality Healthcare. This medication can help reduce the discomfort of osteoarthritis while also delaying or avoiding knee replacement surgery. Medicare and many supplemental insurance plans approve this surgery. To understand more about this technique, Vitality is offering a free consultation.


Dec 2021 OrthogenRx, a leader in viscosupplementation therapy for the treatment of knee osteoarthritis (OA) pain, has agreed to be acquired by Avanos Medical, Inc. for $130 million in cash and up to $30 million in contingent cash consideration. The deal was finalized on January 20, 2022.

Segmentation Table


Viscosupplementation Market, By Procedure Type



  • Single-Injection Procedure

  • Three-Injection Procedure

  • Five-Injection Procedure


Viscosupplementation Market, By Hyaluronic Acids



  • Standard Hyaluronic Acid

  • Stabilized Hyaluronic Acid


Viscosupplementation Market, By Application



  • Knee Arthritis

  • Hip Osteoarthritis


Viscosupplementation Market, By End-User



  • Hospitals & Clinics

  • Ambulatory Surgical centers



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: USD 5,243.19 Million
  CAGR   2018-2023: 10.48%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Procedure Type, Hyaluronic Acid Type, Application, and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan, Sanofi, Hoffmann-La Roche, Smith & Nephew Plc, Zimmer Biomet, Anika Therapeutics Inc., Ferring B.V., Bioventus, Fidia Farmaceutici S.P.A., Regen Lab SA
  Key Market Opportunities   Growing Demand From Emerging Nations
  Key Market Drivers

  • Increasing Patient Pool Suffering From Knee Osteoarthritis
  • Rising Popularity Of Minimally Invasive Procedures
  • Increasing Geriatric Population


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Viscosupplementation is the process of injecting lubricating fluid such as hyaluronic acid into joints to ease the movement of the joint.

    The growing prevalence of arthritis is likely to be the major driver for the global viscosupplementation market.

    The global viscosupplementation market is expected to rise to a valuation of USD 5.2 billion during the forecast period.

    The global viscosupplementation market is expected to exhibit a solid 8.96% CAGR over the forecast period from 2020 to 2027.

    Leading players in the viscosupplementation market include Sanofi, F. Hoffman-La Roche, Zimmer Biomet, Smith & Nephew plc, Ferring BV, and Bioventus, among others.